US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class III · Low risk Ongoing

Estradiol Transdermal System

Reason Failed Impurities/Degradation Specifications.

Zydus Pharmaceuticals (USA) Inc NDC 70710-1192-8 D-0542-2024
Class III · Low risk Ongoing

Pregabalin Capsules 50mg

Reason Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.

Rising Pharma Holding, Inc. NDC 64980-411-10 D-0541-2024
Class II · Moderate risk Ongoing

Klarity-C

Reason Lack of Assurance of Sterility

Imprimis NJOF, LLC D-0547-2024
Class II · Moderate risk Ongoing

Dexamethasone-Moxifloxacin

Reason Lack of Assurance of Sterility

Imprimis NJOF, LLC NDC 71384-512-01 D-0513-2024
Class II · Moderate risk Ongoing

Rizatriptan Benzoate Orally Disintegrating Tablets

Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Glenmark Pharmaceuticals Inc., USA NDC 68462-468-06 D-0535-2024
Class II · Moderate risk Ongoing

Rizatriptan Benzoate Orally Disintegrating Tablets

Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Glenmark Pharmaceuticals Inc., USA NDC 68462-467-06 D-0534-2024
Class III · Low risk Ongoing

Cephalexin for Oral Suspension

Reason Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g'

Bryant Ranch Prepack, Inc. NDC 63629-9207-1 D-0540-2024
Class III · Low risk Ongoing

Cephalexin for Oral Suspension

Reason Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g'

Bryant Ranch Prepack, Inc. NDC 63629-9206-1 D-0539-2024
Class III · Low risk Ongoing

Cephalexin for Oral Suspension

Reason Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g'

Bryant Ranch Prepack, Inc. NDC 63629-8858-1 D-0538-2024
Class III · Low risk Ongoing

Cephalexin for Oral Suspension

Reason Labeling: Not Elsewhere Classified: Back label states Each contains: cephalexin monohydrate, USP equivalent to 2.5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g

Bryant Ranch Prepack, Inc. NDC 63629-9205-1 D-0537-2024
Class III · Low risk Ongoing

Cephalexin for Oral Suspension

Reason Labeling: Not Elsewhere Classified: Front label states 100 Tablets instead of 100 ml and on the back label 'Each Tablet contains' instead of 'Each Bottle contains' No total dose per bottle listed should be 2.5 g'

Bryant Ranch Prepack, Inc. NDC 63629-9204-1 D-0536-2024
Class II · Moderate risk Ongoing

Rizatriptan Benzoate Tablets USP

Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Glenmark Pharmaceuticals Inc., USA NDC 68462-466-99 D-0533-2024
Class II · Moderate risk Ongoing

Rizatriptan Benzoate Tablets USP

Reason CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Glenmark Pharmaceuticals Inc., USA NDC 68462-465-99 D-0532-2024
Class II · Moderate risk Ongoing

Duloxetine Delayed-Release Cap USP 30mg

Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Preferred Pharmaceuticals, Inc. NDC 68788-9301-03 D-0505-2024
Class II · Moderate risk Ongoing

Drug Vial Label: Zilretta¿

Reason Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.

Pacira Pharmaceuticals INC NDC 65250-001-01 D-0546-2024
Class II · Moderate risk Ongoing

Metoprolol Tartrate Tablets USP

Reason Presence of Foreign Substance: metal in tablet

Rubicon Research Private Limited NDC 52817-360-00 D-0517-2024